Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 2 , Pages 148-153, March 2007

Herpes simplex virus infection, massive pulmonary thromboembolism, and right atrial thrombi in a single patient: Case report

  • Aslı Görek, MD

      Affiliations

    • Başkent University Faculty of Medicine, Department of Pulmonary Diseases, Beşevler/Ankara, Turkey
    • Corresponding Author InformationReprint requests: Aslı Görek, MD, Başkent University Faculty of Medicine, Department of Pulmonary Diseases, Mareşal Fevzi Çakmak Bulvarı 5, Sokak No: 48, Beşevler/Ankara, Turkey.
  • ,
  • Şule Akçay, MD

      Affiliations

    • Başkent University Faculty of Medicine, Department of Pulmonary Diseases, Beşevler/Ankara, Turkey
  • ,
  • Oya Altas İbiş, MD

      Affiliations

    • Başkent University Faculty of Medicine, Department of Pulmonary Diseases, Beşevler/Ankara, Turkey
  • ,
  • İlyas Atar, MD

      Affiliations

    • Başkent University Faculty of Medicine, Cardiology Department, Beşevler/Ankara, Turkey.
  • ,
  • Füsun Öner Eyüboğlu

      Affiliations

    • Başkent University Faculty of Medicine, Department of Pulmonary Diseases, Beşevler/Ankara, Turkey

We report a 32-year-old man with herpes simplex virus encephalitis who developed massive pulmonary thromboembolism with mobile right atrial thrombi during treatment for this condition. It was not safe to use thrombolytic therapy because of the high risk of cerebral bleeding associated with encephalitis. The patient was initially treated at another center, but his condition deteriorated during nadroparin therapy and he was referred to our hospital. Nadroparin was discontinued, and a continuous infusion of unfractionated heparin was administered through a central venous catheter. The patient’s general status improved over the next 24 hours, and all thrombi in the right atrium disappeared. There was immediate lysis of the thrombi after the continuous infusion of unfractionated heparin was initiated. We suggest that central-line infusion of this agent is preferable to peripheral infusion in such cases. Further research on the potential thrombolytic effect of heparin is needed.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0147-9563(06)00132-4

doi:10.1016/j.hrtlng.2006.06.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 2 , Pages 148-153, March 2007